Viewing Study NCT05528666


Ignite Creation Date: 2025-12-24 @ 4:15 PM
Ignite Modification Date: 2026-01-07 @ 9:51 AM
Study NCT ID: NCT05528666
Status: COMPLETED
Last Update Posted: 2022-11-08
First Post: 2022-09-02
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Risk Perception in Multiple Sclerosis
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Sclerosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Multiple sclerosis (MS), View
None Disease-modifying therapies (DMTs), View
None High efficacy treatments (HETs), View
None Nonhigh efficacy treatments (Non-HETs) View